Etanercept in patients with moderate to severe plaque psoriasis: a retrospective case cohort analysis

被引：0
|
作者：
Perera, G. [1 ]
Fonia, A. [1 ]
Smith, C. [1 ]
Barker, J. N. W. N. [1 ]
机构：
[1] St Johns Inst Dermatol, London, England
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2009年 / 161卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [31] Evaluation of Patient-Reported Outcomes With Etanercept in Moderate to Severe Plaque Psoriasis Patients After Therapy With Apremilast
    Bagel, Jerry
    Stolshek, Bradley S.
    Yang, Yue
    Kricorian, Gregory
    Kircik, Leon H.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2020, 19 (04) : 378 - 383
  • [32] A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis
    Lebwohl, Mark G.
    Kircik, Leon
    Duffin, Kristina Callis
    Pariser, David
    Hooper, Michele
    Wenkert, Deborah
    Thompson, Elizabeth H. Z.
    Yang, Jun
    Kricorian, Greg
    Koo, John
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 69 (03) : 385 - 392
  • [33] Real-World Clinical Experience With Apremilast in a Large US Retrospective Cohort Study of Patients With Moderate to Severe Plaque Psoriasis
    Armstrong, April
    Levi, Eugenia
    JOURNAL OF DRUGS IN DERMATOLOGY, 2017, 16 (12) : 1240 - 1245
  • [34] Effectiveness of guselkumab in patients with moderate-to-severe plaque psoriasis: a retrospective study from China
    Huang, He
    Liu, Hao
    Zhu, Zhengwei
    Wang, Wenjun
    Liang, Bo
    Tang, Huayang
    Yang, Sen
    Sheng, Yujun
    Sun, Liangdan
    Zhang, Xuejun
    EUROPEAN JOURNAL OF DERMATOLOGY, 2024, 34 (01) : 73 - 78
  • [35] Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study
    Schwensen, J. F.
    Clemmensen, A.
    Sand, C.
    Gniadecki, R.
    Skov, L.
    Zachariae, C.
    Iversen, L.
    Rasmussen, M.
    Thomsen, S. F.
    DERMATOLOGIC THERAPY, 2017, 30 (06)
  • [36] Pattern of response in patients with moderate-to-severe psoriasis treated with etanercept
    Griffiths, C. E. M.
    Sterry, W.
    Brock, F.
    Dilleen, M.
    Stefanidis, D.
    Germain, J. M.
    Mallbris, L.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 172 (01) : 230 - 238
  • [37] Improvement in the psoriasis symptom inventory in moderate-to-severe psoriasis patients on etanercept or adalimumab
    Patel, Mira
    Martin, Mona
    Ortmeier, Brian
    Kricorian, Greg
    Wade, Sally
    Stolshek, Bradley
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB163 - AB163
  • [38] Joint pain improvement in patients on etanercept therapy for moderate to severe psoriasis
    Tyring, Stephen
    Kricorian, Gregory
    Gordon, Kenneth
    Klekotka, Paul
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB158 - AB158
  • [39] Remicade® in moderate to severe plaque psoriasis
    Ortonne, J. -P.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2006, 133 (05): : 1S13 - 1S17
  • [40] Cost-efficacy of adalimumab, etanercept, infliximab and ustekinumab for moderate-to-severe plaque psoriasis
    Ferrandiz, C.
    Garcia, A.
    Blasco, A. J.
    Lazaro, P.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2012, 26 (06) : 768 - 777
12345